• Accueil
• tpex
• Taxane-based TPEx shows promise for head, neck cancer, Latest news for Doctors, Nurses and Pharmacists

Taxane-based TPEx shows promise for head, neck cancer, Latest news for Doctors, Nurses and Pharmacists

4.8 (442) · € 20.50 · En Stock

The taxane-based TPEx regimen demonstrated encouraging overall survival (OS) benefit for recurrent/metastatic head and neck squamous cell carcinoma (R

Study: Active Surveillance an Effective Option for Thyroid Cancer

Head and Neck Cancer Treatment - Atlantic Health

Head & Neck Cancer Treatment & Evaluation

Tanda Hicks, FNP-C, Family Medicine in Wheatland, WY

Jessica Turner - Registered Nurse - Penn Medicine, University of

American Society of Clinical Oncology 47th Annual Meeting Meeting

Kelly Jackson, C-FNP U.S. Dermatology Partners Nacogdoches

Drug Combo Shows Promise Against Advanced Head and Neck Cancer

Ask The Doctor - Texas Healthcare Neck & Back Clinics P.A.

Frontiers A systemic review of taxanes and their side effects in

Team – Las Vegas Headache

Tamika M. Turner, DNP, NP-C, AOCNP - Arizona Oncology

Danniell Hicks, APRN, MSN, FNP-C - Endocrinology

Nicki Thorne, FNP Circle Medical, Alexandria, VA